FXAIX | LCCAX | FXAIX / LCCAX | |
Total Expense Ratio | 0.01 | 0.99 | 2% |
Annual Report Gross Expense Ratio | 0.01 | 0.99 | 2% |
Fund Existence | 14 years | 27 years | - |
Gain YTD | -3.872 | -4.804 | 81% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 2000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 594B | 13.7B | 4,336% |
Annual Yield % from dividends | 1.34 | 0.33 | 400% |
Returns for 1 year | 10.00 | -2.45 | -409% |
Returns for 3 years | 47.66 | 20.76 | 230% |
Returns for 5 years | 107.31 | 34.99 | 307% |
Returns for 10 years | 192.42 | 53.22 | 362% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 20.28 | 0.16 | +0.80% |
ProShares UltraShort Nasdaq Biotech | |||
QCON | 45.82 | 0.33 | +0.73% |
American Century Quality Cnvtbl Scts ETF | |||
EAD | 6.74 | 0.02 | +0.30% |
Allspring Income Opportunities Fund | |||
SIVR | 30.87 | -0.05 | -0.16% |
abrdn Physical Silver Shares ETF | |||
GBF | 102.95 | -0.48 | -0.46% |
iShares Government/Credit Bond ETF |